210 related articles for article (PubMed ID: 19734449)
1. Inactivating SOCS1 mutations are caused by aberrant somatic hypermutation and restricted to a subset of B-cell lymphoma entities.
Mottok A; Renné C; Seifert M; Oppermann E; Bechstein W; Hansmann ML; Küppers R; Bräuninger A
Blood; 2009 Nov; 114(20):4503-6. PubMed ID: 19734449
[TBL] [Abstract][Full Text] [Related]
2. Somatic hypermutation of SOCS1 in lymphocyte-predominant Hodgkin lymphoma is accompanied by high JAK2 expression and activation of STAT6.
Mottok A; Renné C; Willenbrock K; Hansmann ML; Bräuninger A
Blood; 2007 Nov; 110(9):3387-90. PubMed ID: 17652621
[TBL] [Abstract][Full Text] [Related]
3.
Schuhmacher B; Bein J; Rausch T; Benes V; Tousseyn T; Vornanen M; Ponzoni M; Thurner L; Gascoyne R; Steidl C; Küppers R; Hansmann ML; Hartmann S
Haematologica; 2019 Feb; 104(2):330-337. PubMed ID: 30213827
[TBL] [Abstract][Full Text] [Related]
4. Aberrant somatic hypermutation in tumor cells of nodular-lymphocyte-predominant and classic Hodgkin lymphoma.
Liso A; Capello D; Marafioti T; Tiacci E; Cerri M; Distler V; Paulli M; Carbone A; Delsol G; Campo E; Pileri S; Pasqualucci L; Gaidano G; Falini B
Blood; 2006 Aug; 108(3):1013-20. PubMed ID: 16614247
[TBL] [Abstract][Full Text] [Related]
5. Aberrant somatic hypermutation in multiple subtypes of AIDS-associated non-Hodgkin lymphoma.
Gaidano G; Pasqualucci L; Capello D; Berra E; Deambrogi C; Rossi D; Maria Larocca L; Gloghini A; Carbone A; Dalla-Favera R
Blood; 2003 Sep; 102(5):1833-41. PubMed ID: 12714522
[TBL] [Abstract][Full Text] [Related]
6. Primary mediastinal B-cell lymphoma: hypermutation of the BCL6 gene targets motifs different from those in diffuse large B-cell and follicular lymphomas.
Malpeli G; Barbi S; Moore PS; Scardoni M; Chilosi M; Scarpa A; Menestrina F
Haematologica; 2004 Sep; 89(9):1091-9. PubMed ID: 15377470
[TBL] [Abstract][Full Text] [Related]
7. Suppressor of cytokine signaling 1 gene mutation status as a prognostic biomarker in classical Hodgkin lymphoma.
Lennerz JK; Hoffmann K; Bubolz AM; Lessel D; Welke C; Rüther N; Viardot A; Möller P
Oncotarget; 2015 Oct; 6(30):29097-110. PubMed ID: 26336985
[TBL] [Abstract][Full Text] [Related]
8. Targeting of somatic hypermutation.
Odegard VH; Schatz DG
Nat Rev Immunol; 2006 Aug; 6(8):573-83. PubMed ID: 16868548
[TBL] [Abstract][Full Text] [Related]
9. AID is expressed in germinal center B-cell-like and activated B-cell-like diffuse large-cell lymphomas and is not correlated with intraclonal heterogeneity.
Lossos IS; Levy R; Alizadeh AA
Leukemia; 2004 Nov; 18(11):1775-9. PubMed ID: 15385936
[TBL] [Abstract][Full Text] [Related]
10. Immunoglobulin gene analysis of mature B-cell malignancies: reconsideration of cellular origin and potential antigen involvement in pathogenesis.
Walsh SH; Rosenquist R
Med Oncol; 2005; 22(4):327-41. PubMed ID: 16260850
[TBL] [Abstract][Full Text] [Related]
11. Alterations of negative regulators of cytokine signalling in immunodeficiency-related non-Hodgkin lymphoma.
Capello D; Gloghini A; Baldanzi G; Martini M; Deambrogi C; Lucioni M; Piranda D; Famà R; Graziani A; Spina M; Tirelli U; Paulli M; Larocca LM; Gaidano G; Carbone A; Sinigaglia F
Hematol Oncol; 2013 Mar; 31(1):22-8. PubMed ID: 22488585
[TBL] [Abstract][Full Text] [Related]
12. Expression of activation-induced cytidine deaminase in human B-cell non-Hodgkin lymphomas.
Greeve J; Philipsen A; Krause K; Klapper W; Heidorn K; Castle BE; Janda J; Marcu KB; Parwaresch R
Blood; 2003 May; 101(9):3574-80. PubMed ID: 12511417
[TBL] [Abstract][Full Text] [Related]
13. SOCS1 mutation subtypes predict divergent outcomes in diffuse large B-Cell lymphoma (DLBCL) patients.
Schif B; Lennerz JK; Kohler CW; Bentink S; Kreuz M; Melzner I; Ritz O; Trümper L; Loeffler M; Spang R; Möller P
Oncotarget; 2013 Jan; 4(1):35-47. PubMed ID: 23296022
[TBL] [Abstract][Full Text] [Related]
14. Primary cutaneous follicle center lymphoma and primary cutaneous large B-cell lymphoma, leg type, are both targeted by aberrant somatic hypermutation but demonstrate differential expression of AID.
Dijkman R; Tensen CP; Buettner M; Niedobitek G; Willemze R; Vermeer MH
Blood; 2006 Jun; 107(12):4926-9. PubMed ID: 16507780
[TBL] [Abstract][Full Text] [Related]
15. Aberrant somatic hypermutation in transformation of follicular lymphoma and chronic lymphocytic leukemia to diffuse large B-cell lymphoma.
Rossi D; Berra E; Cerri M; Deambrogi C; Barbieri C; Franceschetti S; Lunghi M; Conconi A; Paulli M; Matolcsy A; Pasqualucci L; Capello D; Gaidano G
Haematologica; 2006 Oct; 91(10):1405-9. PubMed ID: 17018394
[TBL] [Abstract][Full Text] [Related]
16. M17, a gene specific for germinal center (GC) B cells and a prognostic marker for GC B-cell lymphomas, is dispensable for the GC reaction in mice.
Schenten D; Egert A; Pasparakis M; Rajewsky K
Blood; 2006 Jun; 107(12):4849-56. PubMed ID: 16493007
[TBL] [Abstract][Full Text] [Related]
17. Genome-wide detection of genes targeted by non-Ig somatic hypermutation in lymphoma.
Jiang Y; Soong TD; Wang L; Melnick AM; Elemento O
PLoS One; 2012; 7(7):e40332. PubMed ID: 22808135
[TBL] [Abstract][Full Text] [Related]
18. Structural analysis and conformational dynamics of SOCS1 gene mutations involved in diffuse large B-cell lymphoma.
Dristy TT; Noor AR; Dey P; Saha A
Gene; 2023 May; 864():147293. PubMed ID: 36813059
[TBL] [Abstract][Full Text] [Related]
19. Determining the Origin of Human Germinal Center B Cell-Derived Malignancies.
Seifert M; Küppers R
Methods Mol Biol; 2017; 1623():253-279. PubMed ID: 28589362
[TBL] [Abstract][Full Text] [Related]
20. Improved clonality assessment in germinal centre/post-germinal centre non-Hodgkin's lymphomas with high rates of somatic hypermutation.
Catherwood MA; Gonzalez D; Patton C; Dobbin E; Venkatraman L; Alexander HD
J Clin Pathol; 2007 May; 60(5):524-8. PubMed ID: 16816169
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
